Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis.

Lu, Thomas Chengxuan; Collins, Luke; Cohen, Penelope; Jay, Alex; Campbell, Jared M; O'Callaghan, Michael

Lu, Thomas Chengxuan; Collins, Luke; Cohen, Penelope; Jay, Alex; Campbell, Jared M; O'Callaghan, Michael.

Afiliação

Lu TC; The George Institute for Global Health, UNSW, Sydney, NSW, 2052, Australia. thomascxlu@gmail.com.
Collins L; St George Hospital, Kogarah, NSW, 2207, Australia. thomascxlu@gmail.com.
Cohen P; Westmead Hospital, Westmead, NSW, 2145, Australia. thomascxlu@gmail.com.
Jay A; Royal Adelaide Hospital, Adelaide, 5000, Australia.
Campbell JM; SA Pathology, Royal Adelaide Hospital, Adelaide, Australia.
O'Callaghan M; Urology Unit, Flinders Medical Centre, Bedford Park, Australia.

Pathol Oncol Res ; 26(3): 1367-1375, 2020 Jul.

Article em En | MEDLINE | ID: mdl-30875031

Assuntos

Gradação de Tumores; Neoplasias da Próstata/mortalidade; Neoplasias da Próstata/patologia; Humanos; Masculino; Prognóstico

Palavras-chave

Biopsy; Gleason score; Grade group 4; Prostate cancer; Prostate cancer specific mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google